Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Molecular Mechanisms of Lipid-Modifying Enzymes in Cellular Adaptation and Systemic Glucose Homeostasis

Summarise with AI (MRCPsych/FRANZCP)

Compr Physiol. 2026 Apr;16(2):e70125. doi: 10.1002/cph4.70125.

ABSTRACT

Lipid-modifying enzymes dynamically regulate membrane architecture, signaling compartmentalization, and inter-organ metabolic communication, thereby influencing systemic glucose homeostasis. Advances in lipidomics and structural enzymology reveal how enzymatic remodeling of phospholipids, sphingolipids, and acyl chains governs insulin receptor organization, PI3K-AKT signaling, and GLUT4 trafficking. Dysregulated lipid flux mediated by factors such as FABP4, ceramides, and diacylglycerols disrupts membrane microdomains, impairs β-cell function, and promotes hepatic gluconeogenesis and skeletal muscle insulin resistance. Conversely, omega-3 polyunsaturated fatty acids enhance membrane fluidity and anti-inflammatory signaling. Integrating lipid enzymology with metabolic physiology establishes a unified mechanistic framework linking membrane remodeling to insulin responsiveness and diabetes pathogenesis.

PMID:41793053 | DOI:10.1002/cph4.70125

Document this CPD

AI Search

Share Evidence Blueprint

QR Code

Search Google Scholar

Save as PDF

close chatgpt icon
ChatGPT

Enter your request.

Psychiatry AI: Real-Time AI Scoping Review